Petition Gains Momentum Calling on President Obama to Stop the FDA from Limiting Adult Stem Cell Treatment
A petition begun by Claire Hooper, a member of Patients For Stem Cells (www.patientsforstemcells.org), is currently being circulated calling for President Obama to “please stop the FDA’s [Food and Drug Administration] assertion that the use of our body’s own stem cells (AASC) is a ‘biological drug’ and thereby subject to FDA regulation.” AASC stands for Autologous Adult Stem Cells, orstem cells derived from a person’s own tissue.
RSCI Adds New York's ReGen Medical to Its List of the World's Top Stem Cell Clinics
The Repair Stem Cell Institute (RSCI) – www.repairstemcells.org -- is pleased to announce its business alliance with ReGen Medical, PC (www.regenmedicalpc.com) of New York City, making it one of the 14 international stem cell treatment centers RSCI represents. The location on New York’s Park Avenue adds a very high profile visibility to RSCI’s commitment to education and services in the area of adult stem cell treatment.
The Repair Stem Cell Institute Invites Participation in a Unique Clinical Trial for COPD
The Repair Stem Cell Institute (RSCI) – http://www.repairstemcells.org -- is pleased to announce that it will assist interested patients to take part in a clinical trial based in the United States for the treatment of COPD (Chronic Obstructive Pulmonary Disease). The FDA approved and compliant trial, which uses adult stem cells, will be conducted only during January 2014 in the U.S. states of Florida and Georgia.
Adult Stem Cell Treatment Poised to Be in the Forefront of 21st Century Medicine
In the past decade, international stem cell treatment has grown by leaps and bounds to the point where it is poised to become the most effective treatment for chronic conditions and diseases. Currently, adult stem cell treatment is being used to help patients recover from over 150 debilitating chronic conditions previously thought to be untreatable, including the “Big Three” – Heart Disease, Diabetes, and Cancer. To date, commercial stem cell treatments have been used by over 30,000 patients with a more than 65% success rate.